59 results
8-K
EX-99.1
VRNA
Verona Pharma plc
27 Jun 24
Ohtuvayre is indicated for the maintenance treatment of COPD allowing for broad use in COPD patients
6:02am
and despite available treatment options, it is the third leading cause of death globally.
1Adeloye D, et al. Lancet Respir Med. 2022;10(5):447-458
PRE 14A
3xi ay0es
8 Mar 24
Preliminary proxy
4:18pm
8-K
EX-10.1
cxc0hkfnb
1 Sep 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
fvz34r 9jep
1 May 23
Departure of Directors or Certain Officers
5:21pm
424B5
fkohvz
11 Aug 22
Prospectus supplement for primary offering
5:09pm
424B5
iwac myb1gxizwf
9 Aug 22
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
y2k4hx4
11 Aug 21
Departure of Directors or Certain Officers
4:27pm
10-Q
4rv4i c0h6ch
29 Apr 21
Quarterly report
7:43am
S-3
7ioftsd lrb3o
19 Mar 21
Shelf registration
5:23pm
POS AM
mxydiceonn
19 Mar 21
Prospectus update (post-effective amendment)
4:56pm